Search
for

    Research 5 of 53

    1. Ritlecitinib (Litfulo) Canadian Journal of Health Technologies · 2026
    2. La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME) · 2023
    3. Ritlecitinib: First Approval Drugs · 2023 · 84 citations
    4. Ritlecitinib in severe alopecia areata: a profile of its use Drugs & Therapy Perspectives · 2024
    5. First drug for severe alopecia recommended by NICE could benefit 14,000 patients 2024
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →